Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Lavender scent tested as quick stress relief for ER patients

NCT ID NCT07328412

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a 5-minute session of smelling lavender essential oil can help reduce stress, anxiety, and improve satisfaction in emergency department patients. 60 adults admitted to the ER observation unit took part. Half received a lavender-scented tube to sniff, while the other half got an unscented tube. The main goal was to see if the approach was acceptable and easy to use, not yet to prove it works for everyone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
lavender essential oil
What this could lead to
If it works, this could offer a simple, drug-free way to help patients feel calmer in the emergency department.
What could go wrong
This was a small, early feasibility study with only 60 participants. The results may not apply to all patients, and the effect may be due to the relaxing setting rather than the lavender itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Feb 2026

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults ≥18 years of age * Admitted to the BWH Emergency Department (ED) Observation Unit * Able to provide written informed consent * Willing to participate in a 1-hour aromatherapy session Exclusion Criteria: * Acutely ill and unable to be approached for research, as determined by the treating medical team and/or physician investigator * Active gastrointestinal problems at the time of enrollment (e.g., nausea, vomiting, abdominal cramping, diarrhea), as determined by the treating team and/or physician investigator. * Pregnancy or breastfeeding * Current or planned treatment using sedating medications * History of, or current presentation with, significant cognitive impairment or acute delirium that would preclude informed consent or participation * Currently receiving supplemental oxygen * Acute exacerbation of asthma or COPD * Admission for an acute upper or lower respiratory tract illness (e.g., pneumonia, bronchitis, influenza, COVID-19) * Known allergy or sensitivity to lavender * Documented history of anosmia (loss of smell) * Documented hypotension during current ED presentation, defined as systolic blood pressure \<90 mmHg * Assigned clinical staff (physician, nurse, or other healthcare provider) with fragrance sensitivity prior to consent * Concurrent enrollment in another interventional drug or behavioral trial * Any condition that, in the judgment of the treating team or physician investigator, would make study participation unsafe or inappropriate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.